MetaCap

Contineum Therapeutics Insider Trades

NASDAQ: CTNMHealth CareBiotechnology: Pharmaceutical PreparationsUSD

8.68-0.36 (-3.98%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
31 · $1.86M
Shares bought / sold
0 / 122.70K
Net activity
Net selling $1.9 million

Contineum Therapeutics insider activity

Over the last 12 months, Contineum Therapeutics insiders reported 51 transactions on SEC Form 4: 0 open-market purchases and 31 sales. Insiders bought $0 and sold $1.9 million worth of stock, for net insider selling of $1.9 million. The largest seller was Lorrain Daniel S., with $1.1 million in reported sales.

The most recent filing shows Stengone Carmine N. (CEO and President) reporting a transaction in 2,500 shares at $1.01 on Sep 8, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CTNM's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

CTNM insider transactions

Contineum Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Sep 8, 2026Stengone Carmine N.CEO and PresidentSale2,500$41.14KForm 4
Sep 8, 2026Stengone Carmine N.CEO and PresidentOption exercise2,500$2.52KForm 4
Aug 3, 2026Stengone Carmine N.CEO and PresidentSale2,500$40.03KForm 4
Aug 3, 2026Stengone Carmine N.CEO and PresidentOption exercise2,500$2.52KForm 4
Jul 9, 2026Lorrain Daniel S.Chief Scientific OfficerSale25$400Form 4
Jul 9, 2026Lorrain Daniel S.Chief Scientific OfficerOption exercise25$25.25Form 4
Jul 8, 2026Stengone Carmine N.CEO and PresidentSale2,500$40.00KForm 4
Jul 8, 2026Stengone Carmine N.CEO and PresidentOption exercise2,500$2.52KForm 4
Jul 8, 2026Lorrain Daniel S.Chief Scientific OfficerSale1,015$16.24KForm 4
Jul 8, 2026Lorrain Daniel S.Chief Scientific OfficerOption exercise1,015$1.03KForm 4
Jul 1, 2026Lorrain Daniel S.Chief Scientific OfficerSale2,501$40.61KForm 4
Jul 1, 2026Lorrain Daniel S.Chief Scientific OfficerSale5,852$91.68KForm 4
Jul 1, 2026Lorrain Daniel S.Chief Scientific OfficerOption exercise4,183$4.22KForm 4
Jun 30, 2026Stengone Carmine N.CEO and PresidentSale10,000$160.08KForm 4
Jun 30, 2026Stengone Carmine N.CEO and PresidentOption exercise2,500$3.15KForm 4
Jun 30, 2026Stengone Carmine N.CEO and PresidentOption exercise7,500$7.58KForm 4
Jun 30, 2026Watkins TimCMO & Head of DevelopmentSale10,833$173.59KForm 4
Jun 30, 2026Watkins TimCMO & Head of DevelopmentOption exercise10,833$48.75KForm 4
Jun 30, 2026Lorrain Daniel S.Chief Scientific OfficerSale28,826$462.29KForm 4
Jun 30, 2026Lorrain Daniel S.Chief Scientific OfficerOption exercise28,826$29.11KForm 4
Jun 1, 2026Lorrain Daniel S.Chief Scientific OfficerSale4,170$54.86KForm 4
May 1, 2026Lorrain Daniel S.Chief Scientific OfficerSale300$4.15KForm 4
May 1, 2026Lorrain Daniel S.Chief Scientific OfficerSale3,870$50.54KForm 4
Apr 6, 2026Lorrain Daniel S.Chief Scientific OfficerSale4,170$56.01KForm 4
Mar 2, 2026Watkins TimCMO & Head of DevelopmentSale3,611$54.22KForm 4
Mar 2, 2026Watkins TimCMO & Head of DevelopmentOption exercise3,611$16.25KForm 4
Mar 2, 2026Lorrain Daniel S.Chief Scientific OfficerSale4,170$62.59KForm 4
Feb 25, 2026Lorrain Daniel S.Chief Scientific OfficerSale3,824$61.23KForm 4
Feb 25, 2026Lorrain Daniel S.Chief Scientific OfficerOption exercise3,824$3.86KForm 4
Feb 25, 2026Stengone Carmine N.CEO and PresidentSale2,700$43.24KForm 4
Feb 25, 2026Stengone Carmine N.CEO and PresidentOption exercise2,700$3.40KForm 4
Feb 24, 2026Lorrain Daniel S.Chief Scientific OfficerSale4,300$68.94KForm 4
Feb 24, 2026Lorrain Daniel S.Chief Scientific OfficerOption exercise4,300$4.34KForm 4
Feb 24, 2026Stengone Carmine N.CEO and PresidentSale4,400$70.49KForm 4
Feb 24, 2026Stengone Carmine N.CEO and PresidentOption exercise4,400$5.54KForm 4
Feb 19, 2026Lorrain Daniel S.Chief Scientific OfficerSale100$1.60KForm 4
Feb 19, 2026Lorrain Daniel S.Chief Scientific OfficerOption exercise100$101Form 4
Feb 11, 2026Lorrain Daniel S.Chief Scientific OfficerSale400$6.40KForm 4
Feb 11, 2026Lorrain Daniel S.Chief Scientific OfficerOption exercise400$404Form 4
Feb 11, 2026Stengone Carmine N.CEO and PresidentSale400$6.40KForm 4
Feb 11, 2026Stengone Carmine N.CEO and PresidentOption exercise400$504Form 4
Feb 3, 2026Lorrain Daniel S.Chief Scientific OfficerSale1,170$17.84KForm 4
Feb 3, 2026Lorrain Daniel S.Chief Scientific OfficerSale3,000$44.47KForm 4
Jan 28, 2026Watkins TimCMO & Head of DevelopmentSale811$11.75KForm 4
Jan 28, 2026Watkins TimCMO & Head of DevelopmentSale2,800$39.44KForm 4
Jan 28, 2026Watkins TimCMO & Head of DevelopmentOption exercise3,611$16.25KForm 4
Jan 5, 2026Lorrain Daniel S.Chief Scientific OfficerSale500$5.56KForm 4
Jan 5, 2026Lorrain Daniel S.Chief Scientific OfficerSale3,670$37.98KForm 4
Dec 29, 2025Watkins TimCMO & Head of DevelopmentSale3,611$43.56KForm 4
Dec 29, 2025Watkins TimCMO & Head of DevelopmentOption exercise3,611$16.25KForm 4
Dec 23, 2025Lorrain Daniel S.Chief Scientific OfficerSale4,170$51.01KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related